
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certification™, highlighting its commitment to fostering an innovative and supportive work environment.
Janux is seeking a Vice President, Clinical Development to lead and execute clinical strategy for a select or ongoing clinical trial program. The role emphasizes clinical oversight, data interpretation, and building relationships with industry experts. It requires a background in the biotech or pharmaceutical industries, with an understanding of GCP/ICH guidelines.
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certification™, highlighting its commitment to fostering an innovative and supportive work environment.